The 3D_MAB project aims to develop 3D biomimetic models of the lung and skin barrier in both healthy and pathological conditions through the use of Bioprinting technology. These models will be used as innovative testing platforms for evaluating the safety and efficacy of drugs and medical devices.
LTTA, in collaboration with TAP Education Foundation, offers training opportunities for teenagers interested in experiencing scientific research activities before starting their academic journey in the Degree Program in Medicine or other life sciences.
More details are available at the link:
https://www.tapeducation.net/nextopenings .
Click here to see an example of the issued certificate.
Development and pilot validation of a portable medical device with integrated bio-photonic imaging and lipidomic testing methodology. Collaborations with Proambiente, CIRI SDV, CFR; Companies: Lipinutragen, Silfradent, HyperSpectral Imaging.
https://biophotomics.eu/
For a detailed project description, please visit the following page
The AI4ChemoBrain project aims to develop a predictive demonstrator for the onset of cognitive complications during and after chemotherapy, for clinical use. The demonstrator will be based on a machine learning/artificial intelligence model trained and validated with preclinical datasets.
Collaborations include: Fondazione IRET (project leader), CIRI-SDV – University of Bologna, CIRI ICT – University of Bologna, Biopharmanet-TEC – University of Parma;
Companies: Alfasigma S.p.A., WellMicro Srl.
The project CUBIBOX (Customized Biological Box) represents an innovative platform for in vitro testing, developed through collaboration among the Tecnopolo Mario Veronesi (TPM), LTTA - Laboratorio per le Tecnologie delle Terapie Avanzate, IRST - Istituto Romagnolo per lo Studio dei Tumori, and companies such as B.Braun Avitum Italy, Rimos, and Ophera.
Collaboration with various regional universities. Cineca Project Leader.